A 24-WEEK, OPEN-LABEL, RANDOMIZED, 2-ARM STUDY TO EVALUATE THE SAFETY ANDTOLERABILITY OF KRX-0502 (FERRIC CITRATE) IN CHILDREN WITH IRON DEFICIENCY ANEMIAASSOCIATED WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE

Project: Research project

Project Details

Description

A 24-WEEK, OPEN-LABEL, RANDOMIZED, 2-ARM STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF KRX-0502 (FERRIC CITRATE) IN CHILDREN WITH IRON DEFICIENCY ANEMIA ASSOCIATED WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
StatusActive
Effective start/end date2/1/2112/31/25

Funding

  • AKEBIA THERAPEUTICS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.